Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
AEMD

AEMD - Aethlon Medical Inc Stock Price, Fair Value and News

$2.66-0.14 (-5.00%)
Market Closed

56/100

AEMD

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

56/100

AEMD

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$3.86

Target 3M

$3.41

Target 6M

$3.56

AEMD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

AEMD Price Action

Last 7 days

-3.6%

Last 30 days

7.3%

Last 90 days

-51.0%

Trailing 12 Months

-94.6%

AEMD RSI Chart

AEMD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

AEMD Valuation

Market Cap

2.0M

Price/Earnings (Trailing)

-0.18

Price/Sales (Trailing)

1.06

Price/Free Cashflow

-0.29

AEMD Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$3.86

Target 3M

$3.41

Target 6M

$3.56

AEMD Fundamentals

AEMD Revenue

Revenue (TTM)

1.9M

Rev. Growth (Yr)

-31.02%

Rev. Growth (Qtr)

-17.28%

AEMD Earnings

Earnings (TTM)

-11.3M

Earnings Growth (Yr)

47.02%

Earnings Growth (Qtr)

15.59%

AEMD Profitability

Return on Equity

-195.94%

Return on Assets

-153.74%

Free Cashflow Yield

-348.48%

AEMD Investor Care

Shares Dilution (1Y)

336.22%

Diluted EPS (TTM)

-56.98

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20252.2M2.1M1.9M0
20243.5M3.2M2.6M2.3M
20233.5M3.7M3.8M3.7M
20222.6M2.9M3.2M3.5M
20212.6M2.7M2.6M2.5M
20202.7M2.7M2.6M2.6M
20192.2M2.3M2.7M2.7M
20181.9M2.0M2.0M2.6M
20172.2M1.9M1.8M1.5M
20162.3M2.3M2.4M2.4M
20151.6M1.7M1.8M2.1M
20141.6M1.7M1.7M1.2M
20131.9M1.7M1.6M1.7M
20121.6M1.7M1.9M1.9M
20111.1M1.3M1.2M1.3M
20100000
Get all data in R, Python etc through our Historical Stock Data APIs

About Aethlon Medical Inc

AEMD
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.
 CEO
 WEBSITEaethlonmedical.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES15

Aethlon Medical Inc Frequently Asked Questions

AEMD is the stock ticker symbol of Aethlon Medical Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Aethlon Medical Inc is 2.03 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check AEMD's fair value in chart for subscribers.

The fair value guage provides a quick view whether AEMD is over valued or under valued. Whether Aethlon Medical Inc is cheap or expensive depends on the assumptions which impact Aethlon Medical Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AEMD.

As of Wed Jan 28 2026, AEMD's PE ratio (Price to Earnings) is -0.18 and Price to Sales (PS) ratio is 1.06. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AEMD PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Aethlon Medical Inc has provided -0.641 (multiply by 100 for percentage) rate of return.